DECOMPRESSION SICKNESS (DCS) is a systemic pathophysiological process that occurs after tissues become supersaturated with gas. Inert gases inhaled while breathing are taken up by tissues in proportion to the ambient pressure, and when pressure is reduced, some of this gas is released from tissues in the form of bubbles (12) . The central role of bubbles as an inciting factor for DCS is widely accepted, but the pathophysiological responses that mediate tissue injury remain unclear. DCS has been associated with endothelial dysfunction, platelet activation, occasional alterations in coagulation pathways, and rare reduction of circulating platelet counts (6, (32) (33) (34) . Neutrophil activation and perivascular adherence are associated with functional deficits after decompression in animal models (27, 31) . DCS is a risk associated with scuba diving, high-altitude aviation, and space exploration.
Circulating microparticles (MPs) are increased in humans subjected to simulated scuba diving (26, 45) . MPs are 0.1-to 1-m-diameter membrane vesicles shed from the surface of cells by what appear to be well-regulated processes (13) . MPs are characterized by their expression of antigenic markers from parent cells. As MPs bud from these cells, negatively charged phosphatidylserine residues are exposed, often leading to secondary binding of annexin V. MPs can directly stimulate release of proinflammatory cytokines, and platelet-derived MPs stimulate leukocyte activation and aggregation (22, 24, 28) . Annexin V-positive platelet MPs exhibit procoagulant activity (9) . Testing the pathological or physiological roles of MPs has been difficult, because methods to remove circulating MPs are limited. We hypothesized that MPs generated on decompression are required for development of tissue injuries. Using novel surfactant-based and antibody infusion methods to abate circulating MPs, we show their involvement with intravascular neutrophil activation and generation of vascular injuries in mice subjected to a range of decompression stresses.
METHODS

Materials.
Unless otherwise noted, chemicals were purchased from Sigma-Aldrich (St. Louis, MO). Antibodies were purchased from sources as described below.
Animals. All aspects of this study were reviewed and approved by the Institutional Animal Care and Use Committee. Wild-type mice (Mus musculus) and myeloperoxidase (MPO) knockout mice were purchased from Jackson Laboratories (Bar Harbor, ME); they were fed a standard rodent diet and water ad libitum and were housed in the animal facility of the University of Pennsylvania. A colony of MPO knockout mice was maintained from breeding pairs. Mice were exposed to elevated pressure in a small hyperbaric chamber (model G15-APSP, Bethlehem Steel). Pressurization and decompression occurred at 200 kPa/min. There were no deaths due to the pressure profiles used in this study. At the times specified in RESULTS, mice were anesthetized [intraperitoneal administration of ketamine (100 mg/kg) and xylazine (10 mg/kg)], skin was prepared by swabbing with povidone-iodine (Betadine), and blood was collected in heparinized syringes by aortic puncture. Blood was immediately combined with commercial fixative (100 l/ml Caltag Reagent A fixation medium, Invitrogen, Carlsbad, CA) before further work was done.
Thrombocytopenia was achieved by injection of antiserum, as previously described (40) . A 0.3% solution (wt/vol) of sterile polyethylene glycol (PEG) telomere B was infused at 0.7 l/g mouse immediately following decompression. Other mice were injected with annexin V antibody (2 g/g mouse iv; BD Pharmingen, San Jose, CA) immediately following decompression.
Flow cytometry. Flow cytometry was performed with a 4-color, dual-laser analog FACSCalibur or 10-color FACSCanto (BectonDickinson, San Jose, CA) using standard acquisition software. Analysis of leukocytes was performed on fixed blood. Erythrocytes were not removed to guard against cell activation that might occur with lysis steps. Assay methods, permeabilization, and compensation procedures were carried out as described in a previous publication (30) . Cells were defined as positive for a particular antigen if linear fluorescence intensity was Ͼ10.
MPs were obtained from fixed blood by a three-step procedure involving an initial centrifugation at 150 g for 20 min to remove cells; then the plasma supernatant was centrifuged at 300 g for 20 min to clarify the platelet-rich plasma. EDTA was added to achieve 0.2 M, plasma was centrifuged for 30 min at 15,000 g, and the supernatant was used for MP analysis. This protocol was established on the basis of pilot trials focused on eliminating cell debris, which was expected to be elevated by decompression stresses. Centrifugation at Ͻ15,000 g resulted in more debris in the supernatant (quantitatively assessed as the Յ10-fluorescence units particles in dot plots of forward vs. side Leukocyte changes with decompression. Neutrophils in blood from decompressed mice were labeled using anti-CD66b. One portion of each cell preparation was used for evaluation of surface expression of CD18, CD41, and myeloperoxidase (MPO); another portion was permeabilized and stained for evaluation of intracellular MPO content. Results from flow cytometry show surface staining and intracellular MPO in cells from mice killed immediately after decompression following exposure to 171, 515, and 1,165 kPa for 2 h. scatter), whereas centrifugation at Ͼ15,000 g or for Ͼ15 min decreased the MP counts in supernatant samples. All reagents and solutions used for MP analysis were sterile and filtered (0.2-m filter).
For four-color FACSCalibur analysis, four tubes containing 50 l of supernatant were mixed with 3 l of annexin V-allophycocyanin (APC) conjugate (BD Pharmingen) in 100 l of annexin binding buffer solution (BD Pharmingen; 1:10 vol/vol in distilled water). Additional antibodies were added to individual tubes as follows: 1) 3 l of FITC-conjugated anti-mouse CD61, FITC-anti-mouse CD42, or Alexa 647-conjugated anti-lysosome-associated membrane protein-1 (LAMP-1; e-Biosciences, San Diego, CA) and 3 l of R-phycoerythrin (PE)-conjugated anti-mouse CD41 (e-Biosciences), 2) FITCconjugated anti-mouse glycophorin A (GlyA; e-Biosciences) and PE-conjugated von Willebrand factor (vWF; BD Pharmingen), 3) FITC-conjugated anti-human CD14 (BD Pharmingen), and 4) FITC-conjugated anti-human CD66b (BD Pharmingen) and RPEconjugated CD146 (BD Pharmingen). All tubes were incubated for 30 min in darkness prior to analysis. Gates were set to include Յ1.0-m particles, with exclusion of background corresponding to debris usually present in buffers.
For FACSCanto analysis, all antibodies (BD Pharmingen) were mouse anti-human (with cross-reaction against mouse antigens). Plasma samples (50 l) were incubated for 30 min in darkness with 5 l of FITC-conjugated anti-annexin V, 5 l of RPE-conjugated anti-CD146, 5 l of peridinin chlorophyll protein complex (PerCP)/ Cy5.5-conjugated anti-CD41, 5 l of PerCP-conjugated anti-CD66b, 5 l of APC-conjugated anti-GlyA, 5 l of Pacific Blue-conjugated anti-CD14, and 5 l of Texas red (TR)-conjugated anti-vWF in a final volume of 100 l of annexin binding buffer solution. After incubation, the sample was diluted to 400 l with annexin binding buffer solution for flow cytometry analysis. Gates were set to include 0.3-to 1.0-m particles, with exclusion of background corresponding to debris usually present in buffers.
Analysis with both flow cytometer protocols involved establishment of true-negative controls by a fluorescence-minus-one analysis and use of isotype-matched irrelevant antibodies at the same concentration and under the same conditions. Forward and side scatter were set at logarithmic gain. Microbeads of various diameters [0.3 m (Sigma) and 1.0 and 3.0 m (Spherotech, Lake Forest, IL)] were used for initial settings and before each experiment to measure MPs as an internal control. The absolute numbers of MPs per milliliter of plasma were determined by counting the proportion of beads and the exact volume of plasma from which MPs were analyzed.
As with other reports comparing results of FACSCanto with FACSCalibur, we found close agreement between instruments for evaluations of total number of MPs in plasma samples. However, we found large differences in measurements of MP subtypes between the two flow cytometers. Marked elevations in estimates of each MP subtype occurred with FACSCalibur vs. FACSCanto. We discerned that the discrepancy arose because Ͻ0.3-m particles, although a relatively small fraction of the total, exhibited a disproportionately greater variety of surface markers from many vascular cells than did larger MPs. FACSCalibur analysis (gate set to evaluate Յ1-m particles) included Ͻ0.3-m particles, contrary to the FACSCanto, where the gate could be specifically set to evaluate only 0.3-to 1.0-m particles. If the FACSCanto gating was enlarged to evaluate all Յ1-m particles, the MP subtype analysis matched that of the FACSCalibur. For example, we analyzed six different MP suspensions from control mice and quantified the MP subpopulation exhibiting annexin V and CD41 on the surface. The FACSCalibur measurement was 48.8 Ϯ 3.5% platelet-derived MPs. With the FACSCanto and with gating set to count all Յ1-m particles, the measurement was 43.8 Ϯ 2.8% [P ϭ not significant (NS) vs. FACSCalibur]. If the FACSCanto was set to consider only 0.3-to 1-m particles, the measurement was 3.1 Ϯ 0.5% platelet-derived MPs (P Ͻ 0.05 vs. alternate gating paradigm). Only data from subtype analyses using FACSCanto gated on 0.3-to 1-m particles are reported.
Control experiments were required to establish the accuracy of quantitative evaluations of MPs in mice injected with anti-annexin V antibodies (2 g/g body wt iv) to reduce circulating MP numbers. Parallel samples of blood were incubated with or without unconjugated annexin V antibody at various concentrations for 30 min before samples were processed, and MPs were stained following the protocol described above using APC-conjugated annexin V antibody. We estimated that mice were injected with ϳ30 g antibody/1 ml blood as a MP abatement strategy, so blood was incubated with unconjugated annexin V antibody at 30 -120 g/ml. Antibody concentrations even fourfold higher than that used in vivo did not alter total or subtype MP count estimates. For example, in four trials, the MP assessment with 120 g/ml anti-annexin V in the suspension differed from a control suspension containing only PBS by Ϫ0.52 Ϯ 0.37% (P ϭ NS). Hence, we conclude that the dose of unconjugated antiannexin V antibody used in mice was insufficient to saturate MP surface epitopes for annexin V.
Solid-phase immunoassay. After blood was removed from anesthetized animals, a thoracotomy was performed, the left heart was cannulated, and the right heart was opened to release perfusate. inhibitor cocktail at 1 g tissue/10 ml, minced with a razor blade in a plastic dish at 4°C, and then broken up with a Teflon pestle using 10 up-and-down strokes at 1,500 rpm. Homogenates were filtered using 50-m nylon mesh and centrifuged at 500 g for 10 min, protein concentration was measured, and samples were combined with 2ϫ SDS buffer. Adequate samples were spotted on nitrocellulose to give 1, 5, 10, and 20 g of protein per spot in triplicate and dried. Background fluorescence was determined and subtracted from fluorescence measured after staining with the desired fluorochromeconjugated antibodies. Blood (1-10 l) from each animal was also spotted onto the individual nitrocellulose papers to allow for contaminating blood corrections. Homogenate samples were routinely assayed for residual blood following our published technique (41) , and appropriate corrections were applied to calculate sequestered neutrophils (CD66b antibody staining) and MPO. Contamination was slight: 0.27 Ϯ 0.08 (SE) l blood/100 l tissue homogenate (n ϭ 126).
Colloidal silica-endothelium isolation technique. Methods were modified from those described by Arjunan et al. (1) . Animals were prepared as described above; after blood was removed, the animals were perfused at 0.5 ml/min for 30 min with a 1% solution of colloidal silica that had been given a positive charge by coating with aluminum chlorohydroxide and suspended in MES-saline at pH 5.0. Then the unbound intravascular silica was removed by perfusion of the mouse with MBS at 0.8 ml/min for 30 min (ϳ24 ml). The bound silica was fixed to endothelium by perfusion with 0.1% sodium polyacrylate in MBS at 0.5 ml/min for 20 min. After 10 min, tissues were removed and homogenized as described above. The homogenates were made 60% (wt/vol) sucrose and centrifuged at 154,000 g for 30 min at 4°C in a swing-bucket rotor. The cell pellets were placed in 2% SDS in 50 mM Tris (pH 7.4), sonicated for 10 s, and heated at 100°C for 5 min, and the silica was removed by centrifugation at 14,000 g for 15 min. Supernatants were loaded onto 4 -12% polyacrylamide gels, subjected to electrophoresis, and transferred to nitrocellulose paper for Western blots using ␤-actin to control for protein loading. Enrichment for endothelium assessed by comparison of caveolin-1 content with that found in standard homogenates differed among tissues, ranging from 25-to 500-fold (data not shown).
Vascular permeability assay. Lysine-fixable tetramethylrhodamine-conjugated dextran (2 ϫ 10 6 Da; Invitrogen) was prepared as a 1:10 dilution of the dextran stock in MBS to yield 0.5 mg/ml. After thoracotomy, blood was removed, and the mouse was perfused with 2 ml of dextran conjugate at 0.3 ml/min and then left undisturbed for 30 min to allow dextran to diffuse into the vascular wall. Residual intravascular dextran was removed by perfusion with MBS at 0.8 ml/min for 30 min. For fixation of the dextran to tissues, the mouse was perfused with 4 ml of 1% buffered formalin at 0.3 ml/min and left in place for 10 min.
To quantify vascular permeability, perivascular dextran uptake in experimental groups was normalized to a value obtained with a control mouse included in each experiment. This was necessary because of variability in molecular weight of the individual lots of dextran. The manufacturer warns that unlabeled dextran is polydispersed and becomes even more heterogeneous during modification and purification. After intravascular formalin fixation, the procedure followed the same steps used for the cationic colloidal silica procedure. Fluorescence in the endothelium-enriched tissue homogenates was measured with a fluorescence spectrometer (555-nm excitation/ 580-emission) and expressed as arbitrary units per milligram of protein. If raw tissue homogenates, rather than endothelium-enriched samples, were used, the fluorescence signal was low, and no discernible difference from control was detected.
Confocal microscopy. Images of MPs, neutrophils, and FITClabeled 1-m beads were acquired using a Zeiss Meta510 confocal microscope equipped with a Plan-Apochromat ϫ63/1.4 numerical aperture oil objective. FITC, RPE, and APC excitation were provided by 488-, 543-, and 644-nm laser lines, respectively, and resulting fluorescence was separated using the following band-pass filters: 500 -530 nm (FITC), 560 -615 nm (RPE), and 650 -710 nm (APC). Pixel size was 101 nm, and pixel dwell time 1.24 s. Confocal pinholes were set to be one optical unit for all three channels. FITC and RPE were assigned green and red colors, respectively. The deep-red fluorophore APC was assigned the false color blue, so colocalized areas between the neutrophils and MPs were purple. The apparent sizes of the 1-m FITC beads were influenced by their axial positions in the confocal in-focus plane and their varying degree of mobility during the imaging acquisition time (1.24 s per pixel).
Images of lysine-fixable tetramethylrhodamine-conjugated dextran in tissues were prepared by sectioning organs on a vibrating microtome (20-and 50-m thick for brain and muscle, respectively). Tissue slices were placed on lysine-coated slides and counterstained with anti-CD66b to image neutrophils adherent to vascular walls. Slides were visualized using a confocal microscope, as previously described (30) .
Statistical analysis. We used Sigmastat software (Systat, Point Richmond, CA) for the statistical analysis. Neutrophil activation was analyzed by two-way ANOVA followed by the Holm-Sidak test. Single comparisons were performed using Student's t-tests.
RESULTS
MPs are elevated by decompression stress. Mice were exposed to ambient air (ϳ100 kPa, control group) or elevated partial pressures of air for 2 h, and blood samples were obtained at 1 or 24 h postdecompression. MPs were identified on the basis of size and surface expression of annexin V. Figure 1 indicates the increase in number of MPs in blood following decompression. The cells where MPs originated were evaluated by surface expression of antigens from platelets (CD41), neutrophils (CD66b), monocytes ϩ neutrophils (CD14), endothelial cells (CD146), and erythrocytes (GlyA). MPs exhibiting vWF (plasma protein synthesized by endothelium and megakaryocytes) were also evaluated. Total number of MPs and all MP subtypes were significantly elevated with decompression from greater pressures at 1 and 24 h ( Fig. 1 ; P Ͻ 0.05, 2-way ANOVA).
In control and decompressed mouse MP samples, all CD41-positive MPs were also positive for CD61 as expected, given that both proteins are components of the platelet ␣ 2 ␤ 3 -integrin. Dual-positive CD41/annexin V-expressing MPs were positive for another platelet surface marker, CD42, in 74.1 Ϯ 0.9% (n ϭ 3) of control MP samples and 84.1 Ϯ 0.3% (n ϭ 3, P ϭ NS) of MPs from mice 1 h after decompression from 790 kPa. There was, however, a notable difference in CD41/annexin V-expressing MPs that expressed LAMP-1. Only 5.0 Ϯ 0.5% (n ϭ 3) of MPs from control mice expressed LAMP-1, whereas 92.9 Ϯ 1.0% (n ϭ 3, P Ͻ 0.05) of CD41/annexin V-expressing MPs from decompressed mice expressed LAMP-1.
The sum of MP subtypes shown in Fig. 1 (bottom) totaled Ͼ100% in samples from mice subjected to decompression from 790 kPa, indicating that MPs interact and share antigens. To analyze this finding further, single MP samples were stained with multiple fluorescent antibodies. As shown in Fig. 2 , MPs exhibiting vWF were most plentiful and concurrently expressed CD41, CD66, CD14, and CD146. Other combinations of surface markers are as shown. MP populations from mice decompressed from 790 kPa demonstrated a pattern of surface marker mixing similar to that of control mice, but the overall percentage of MPs with each surface marker combination increased significantly in mice killed at 1 and at 24 h postdecompression.
Leukocyte activation. Figure 3 shows a series of measurements with neutrophils, identified by CD66b expression, obtained from mice subjected to decompression from different pressures. After progressively more severe decompression, fluorescence intensity on the cell surface was increased for CD41, CD18 (a component of ␤ 2 -integrins), and MPO, with concomitantly lower fluorescence of intracellular MPO. Confocal microscopy indicated that most of the CD41-positive elements were Ͻ1 m (Fig. 4) , consistent with MPs or platelet fragments. Generally, maximum surface MPO staining was observed by 1 h postdecompression, except for transits from very high pressures, when further increases were noted at 24 h. Figure 5 shows surface CD41, CD18, and MPO on neutrophils obtained from mice at 1 or 24 h postdecompression. Significantly more cells exhibited surface fluorescence for these proteins with increased pressure and time based on two-way ANOVA. Mean fluorescence per cell for each condition is also shown. CD41 was significantly different from control for all conditions, and MPO was elevated in all except the 1-h post-286 kPa samples; however, elevations in surface CD18 Fig. 7 . Effects of various interventions on circulating MPs in blood from wild-type ("no intervention") mice, MPO-null mice, wild-type mice treated with anti-platelet antibody (19 h prior to exposure to pressure or, in control animals, 22 h before death), wild-type mice treated with polyethylene glycol (PEG), and wild-type mice treated with antibody against annexin V (immediately after decompression or, in control animals, 24 h before death). A: data from mice that had not been subjected to decompression. B: data from mice that were killed 1 h after decompression from 790 kPa for 2 h. C: data from mice that were killed 24 h after decompression from 790 kPa. Fractions of MP populations that exhibit surface markers for various vascular cell proteins are shown in tables below histograms. #Significantly different from no intervention (by 2-way ANOVA).
were found only on cells from animals killed 24 h after decompression from the highest pressure. There were no significant changes in circulating leukocyte and platelet counts (data not shown). Decompression-induced changes were not peculiar to neutrophils, as there was a progressive elevation of CD41 on circulating leukocytes identified simply as CD18-expressing cells (Fig. 6) .
Roles for platelets and MPO in MP production and neutrophil activation after decompression were investigated in thrombocytopenic and MPO-null mice. The number of circulating MPs was significantly reduced in these mice, even those not subjected to decompression, and there were commensurate changes in the subtypes of MPs (Fig. 7) . Fewer MPs were found in thrombocytopenic and MPO-null mice subjected to decompression from 790 kPa and killed at 1 or 24 h postdecompression.
Changes in neutrophil surface antigen expression in thrombocytopenic and MPO-null mice are shown in Table 1 . Treatment with anti-platelet antibody caused a higher fraction of neutrophils to have CD41 on the cell surface in mice not subjected to decompression, indicative of some platelet fragmentation in the circulation. Results from thrombocytopenic mice at 1 and 24 h after decompression from 790 kPa demonstrated reductions in the fraction of neutrophils expressing CD41, as well as the mean surface fluorescence intensity of CD41, compared with cells from decompressed mice that had not been rendered thrombocytopenic. The fraction of cells expressing elevated CD18 was lower at 1 and 24 h postdecompression, although elevations in CD18 surface density were not significantly altered compared with decompressed mice that did not receive anti-platelet antibody. Thrombocytopenia resulted in lower surface MPO at 1 h postdecompression and slightly fewer cells expressing an elevation in MPO at 24 h postdecompression. Neutrophils from MPO-null mice subjected to decompression exhibited significantly lower surface fluorescence, as well as lower fractions of cells positive for CD41, MPO, and CD18, than cells from wild-type mice. Interpretations of the data are complicated, because cells from MPO-null mice that had not been subjected to decompression exhibited several differences compared with cells from wildtype mice. Notably, however, neutrophils from decompressed mice exhibited no significant elevations in values compared with those from MPO-null mice that had not been subjected to decompression stress.
MP depletion strategies. We hypothesized that surfactants may disperse MPs, because the integrity of their cytoskeleton is unclear, and for some cells, inhibition of cytoskeletal organization accelerates MP formation (3, 15, 16, 47) . We chose to Values are means Ϯ SE (n ϭ 4 -22). Neutrophils were identified by CD66b staining, and coexpression of CD41, myeloperoxidase (MPO), and CD18 was assessed by flow cytometry. Control mice were not subjected to a decompression stress. Where indicated, mice were kept at 790 kPa for 2 h and killed 1 or 24 h later. Some mice received intraperitoneal injections with anti-platelet antiserum 24 h before experimentation to reduce platelet counts by 85-90%. MPO-null mice lacked the gene for MPO. Polyethylene glycol (PEG) and annexin V-IgG groups received the agent intravenously immediately after decompression. Injections into mice not subjected to decompression (control group) were performed 1 h before mice were killed. *P Ͻ 0.05 vs. control group. #P Ͻ 0.05 vs. no intervention in the same animal group (1 or 24 h postdecompression).
investigate PEG telomere B, because it is known to be well tolerated, as it is an agent formerly used in clinical echocardiography trials (4, 18) . Figure 8 shows the dose-and timedependent lysis of MPs in blood obtained from decompressed mice and incubated ex vivo. Figure 7 shows the reduction of MPs in control and decompressed mice injected with a 0.3% solution (wt/vol) of PEG telomere B at 0.7 l/g body wt iv. There were decreases in all subtypes of MPs with treatment. We also performed studies using a monoclonal antibody abatement strategy. Mice were injected with annexin V antibody (2 g/g body wt iv) immediately following decompression. Results were similar to PEG administration.
MP abatement reduces intravascular neutrophil activation. The role of MPs in neutrophil activation was examined by looking at surface expression of markers on CD66b-positive cells (Table 1 ). In control mice not exposed to decompression stress, injection of anti-annexin V or PEG telomere B reduced CD41 fluorescence. PEG treatment also decreased the fraction of cells positive for CD41 and mean fluorescence values for MPO and CD18. Injection with either agent immediately after mice were exposed to 790 kPa diminished most of the elevations normally observed in animals killed at 1 or 24 h postdecompression (Table 1) . These agents had no significant effect on intravascular leukocyte or platelet counts (data not shown).
Tissue neutrophil sequestration after decompression. Confocal microscope images of tissues were examined after vascular channels had been labeled by intravenous infusion of lysinefixable dextran. Figure 9 shows representative images of vessels in the brain and skeletal muscle of a control mouse and a mouse killed 1 h after decompression from 790 kPa. Brain sections from decompressed mice typically exhibited small (Յ1-m) CD66b-positive particles. It appeared that intact neutrophils were adherent to skeletal muscle vessels in decompressed mice. We wished to quantify decompression-induced deposition of neutrophils or neutrophil MPs in a variety of tissues and chose to study brain, omentum, leg muscle, and psoas. Decompression caused elevations of CD66b and MPO based on a solid-phase immunoassay (Fig. 10) . Cleaved caspase-3 was also probed as an apoptosis index but was not detectable.
To improve immunoassay sensitivity, tissue homogenates were enriched for vascular endothelium (1). Mice were exposed to 790 kPa for 2 h and killed at 1 or 24 h postdecompression, and endothelium-enriched homogenates were prepared from tissues. Significant elevations of CD66b, MPO, and cleaved caspase-3 were found after decompression ( Table 2 ). The role of MPs was investigated by injection of mice with anti-annexin V or PEG telomere B immediately after decompression. PEG abrogated elevations in tissues. Antibody infusion reduced values in mice studied 24 h postdecompression, but it did not diminish MPO deposition at 1 h postdecompression in leg muscle or psoas samples.
Increased vascular permeability associated with decompression. Vascular permeability to rhodamine-labeled dextran was significantly elevated in all tissues at 1 and 24 h following decompression from 790 kPa (Table 3) . Intravenous PEG administered immediately after decompression prevented the elevations. Intravenous anti-annexin V prevented elevations at 24 h postdecompression, but not when animals were killed at 1 h postdecompression.
DISCUSSION
This study demonstrates that circulating MPs are elevated by decompression stress, and results provide a pathophysiological link between MPs and tissue injuries. Decompression from greater pressures results in higher MP loads from a variety of cell types. MP production is a dynamic process, because the number of MPs in the bloodstream increases for Ն24 h postdecompression. Moreover, MPs interact after they are formed, because antigenic markers from a variety of vascular cells are present on the same MPs, and this mixing is more prominent in samples at 24 h than 1 h postdecompression. Antigen sharing between MPs and vascular cells has been described, but to our knowledge, this is the first evidence of the phenomenon in vivo (25) .
MPs have been found to play roles in a number of pathological processes (14, 19) . On the basis of ex vivo studies, lymphocyte MPs compromise endothelial vascular reactivity, induce proinflammatory proteins, and cause oxidative stress by stimulating endothelial cell NADPH oxidase; erythrocyte MPs accelerate coagulation and adhere to endothelium; plateletderived MPs activate neutrophils; and endothelial-and neutro- phil-derived MPs induce platelet aggregation (7, 14) . Accelerated intravascular coagulation by MPs in vivo due to cancer cell-derived MPs was demonstrated using monoclonal antibodies to remove them from the circulation (42) .
Our results with thrombocytopenic mice indicate that plateletderived MPs are especially important for neutrophil activation after decompression. Over 92% of CD41/annexin V dual-positive MPs in decompressed mice express LAMP-1, whereas only 5% of MPs from control mice express this protein. Others reported LAMP-1 expression on MPs derived from activated platelets, but not on MPs derived from megakaryocytes (15) . We conclude that the vast majority of MPs in control mice originate from megakaryocytes, consistent with other reports; however, activated platelets are the predominant source of CD41-positive MPs in decompressed mice. Results from MPO-null mice are consistent with data showing that MPO on the neutrophil surface can cause autoactivation (23) . We conclude that neutrophil activation/degranulation following decompression involves interactions with platelet-derived MPs and that MPO adherent to the cell surface exacerbates neutrophil activation. Furthermore, as the total number of circulating MPs was lower in thrombocytopenic and MPOnull mice, it appears that neutrophil activation leads to generation of MPs from other cells, such as erythrocytes and endothelial cells.
We examined neutrophil sequestration in brain, omentum, leg muscle, and psoas. Symptoms of DCS are variable, even when individuals suffer the same decompression stresses (10, 46) . Therefore, we wanted to investigate whether there may be differences in tissue responses, although MPs are expected to circulate to all organs. Brain was chosen, because among recreational scuba divers with DCS, neurological symptoms are reported in 80% of cases (17) . Decompression stress induces the formation of venous gas bubbles from predominantly fatty tissue; hence, we chose to examine omentum. Our reasoning for using two different muscle types was based on differences in their dynamic properties (8) . Exertion has complex effects on the propensity for bubble formation and DCS (44) .
Decompression caused elevations of CD66b and MPO, and the patterns of elevations differed among the tissues. Neutro- Fig. 9 . Sequestration of neutrophils and dextran in vascular channels. Confocal microscope images of brain and skeletal muscle were obtained from a control mouse and a mouse killed 1 h after decompression from 790 kPa and infused with lysine-fixable rhodamine-dextran (2 ϫ 10 6 Da) and FITC-conjugated anti-CD66b. Size of CD66b-positive particles in brain samples from decompressed mice varied, some substantially Ͻ1 m; size of CD66b-positive particles in skeletal muscle was typically consistent with the size of intact neutrophils. More intense rhodamine staining in decompressed tissues suggests a capillary leak (quantified in Table 3 ).
phil MPs appear to be sequestered in the brain. We rarely found intact neutrophils adherent to brain vessels, but they were easily found in vessels of skeletal muscle. The basis for these differences requires further study. We had expected to find that the magnitude of CD66b and MPO elevations in tissues would rise in parallel. This may have failed to occur because of variable quantities of MPO in the sequestered neutrophils due to intravascular degranulation, as well as deposition of blood-borne MPO and neutrophil MPs.
We used two MP abatement strategies to examine roles for MPs in decompression stress. The ex vivo lytic effect of PEG on MPs prompted its use in this model. Administration of PEG or annexin V antibodies will reduce the number of circulating Values (means Ϯ SE) are expressed as ratio of Western blot band density to density of band using tissue from control animals run on the same blot (therefore, control value ϭ 1.0). Tissue homogenates were enriched for endothelium and analyzed as described in methods. Cap-3, caspase-3. *P Ͻ 0.05 vs. control. Values (means Ϯ SE) are expressed as ratio of fluorescence/mg protein in homogenates from mice subjected to decompression from 790 kPa to fluorescence/mg in homogenates from control mice injected with the same lot of rhodamine-dextran and run on the same day. Endothelium-enriched tissue homogenates were prepared and evaluated as described in methods. *P Ͻ 0.05 vs. control.
MPs, intravascular neutrophil activation, and decompressioninduced tissue injuries. The antibody was not effective at limiting pathological changes in all tissues at just 1 h postdecompression. We conclude that MPs that form early after decompression are an important pathological event. Whether the marked elevation of MPs 24 h postdecompression contributes to progressive pathophysiological changes cannot be discerned from the data.
Infusion of antibody to annexin V would not be anticipated to have clinical utility and may, in fact, induce a procoagulant state (37) . Use of both abatement strategies to support the pathological role for MPs was important, because surfactant agents may directly protect cells from bubble-induced membrane damage (11, 29, 39) . Anti-annexin V and PEG diminished neutrophil activation after decompression (e.g., surface MPO and CD18 expression). It is intriguing that these interventions decreased the presence of CD41 on neutrophils from animals that were not subjected to decompression stress (Table  1 ). Blood samples were fixed immediately after phlebotomy to minimize cell activation, but we cannot definitively state whether CD41-positive MPs are normally present on the surface of leukocytes in vivo.
Tissue injury due to decompression was documented as elevations in caspase-3 and vascular permeability. A role of MPs in decompression-induced injury is supported by the inhibitory effects of the two MP abatement strategies. MPO deposition is expected to cause perivascular oxidative stress, and neutrophil proteases are also likely to compromise vascular integrity (2, 5, 38, 48) . The risk for DCS rises with duration at pressure and the magnitude of depressurization. Decompression following 2 h of exposure to 171 kPa (Figs. 3 and 6 ) is viewed as a relatively safe "no-decompression dive." Emphasis in this study was placed on provocative pressurizations, but it is well recognized that virtually all scuba diving will generate some intravascular bubbles and can lead to DCS. It is also important to recognize that our focus in this study was the pathophysiology of decompression stress. We did not assess functional deficits, nor did we quantify bubbles in blood or tissues, so we cannot state that our study models DCS per se.
A number of mechanisms may be responsible for MP production after decompression. Well-known processes that generate MPs include oxidative stress, cell activation/calcium influx, and apoptosis (14, 19, 36) . Clearly, oxidative stress and apoptosis linked to neutrophil activation may exacerbate MP formation. This is consistent with our findings of markedly higher numbers of MPs at 24 h than at 1 h following decompression. The initial inciting event(s) for MP formation requires further investigation. On the basis of recent reports, bubble-mediated stimulation of calcium-activated big conductance potassium (BK) channels may be a central event leading to MP production (20, 21, 43) .
Our results provide new insight into decompression pathophysiology and, therefore, are relevant for scuba diving, highaltitude aviation, and space exploration. Intervention with PEG, in particular, may be useful when decompression is provocative and might prove to be an effective prophylactic agent or of additive benefit with recompression in a hyperbaric chamber. The surfactant dose we used is far below the toxic dose for primates and similar to that used in clinical echocardiography trials (4, 18) . Beyond their role in DCS, bubbles are an important pathological stressor in vascular surgery and any procedure that may cause iatrogenic air embolism. MP abatement strategies may be useful in many situations when air is accidentally introduced into the circulation.
Given the pathological effects of MPs, abatement with PEG may also prove to be beneficial in conditions where MPs are elevated, such as inflammatory disorders and neoplasia (19) . Because of the promiscuous exchange of surface antigens that occurs among MPs in vivo, MP abatement might be useful for improving targeted delivery of therapeutic agents when antibodies "specific" for a certain cell type are used.
